TCF4 Is a Molecular Target of Resveratrol in the Prevention of Colorectal Cancer

International Journal of Molecular Sciences

Jihye Lee¹  Seong-Ho Lee¹  Jin Boo Jeong¹ 

[1] Department of Nutrition and Food Science, College of Agriculture and Natural Resources,University of Maryland, College Park, MD 20742, USA;

关键词: resveratrol;    phytochemicals;    TCF4;    colon cancer;   

DOI  :  10.3390/ijms160510411

来源: DOAJ

【 摘 要 】

The Wnt/β-catenin pathway plays an essential role in the tumorigenesis of colorectal cancer. T-cell factor-4 (TCF4) is a member of the TCF/LEF (lymphoid enhancer factor) family of transcription factors, and dysregulation of β-catenin is decisive for the initiation and progression of colorectal cancer. However, the role of TCF4 in the transcriptional regulation of its target gene remained poorly understood. Resveratrol is a dietary phytoalexin and present in many plants, including grape skin, nuts and fruits. Although resveratrol has been widely implicated in anti-tumorigenic and pro-apoptotic properties in several cancer models, the underlying cellular mechanisms are only partially understood. The current study was performed to elucidate the molecular mechanism of the anti-cancer activity of resveratrol in human colorectal cancer cells. The treatment of resveratrol and other phytochemicals decreased the expression of TCF4. Resveratrol decreases cellular accumulation of exogenously-introduced TCF4 protein, but did not change the TCF4 transcription. The inhibition of proteasomal degradation using MG132 (carbobenzoxy-Leu-Leu-leucinal) and lactacystin ameliorates resveratrol-stimulateddown-regulation of TCF4. The half-life of TCF4 was decreased in the cells exposedto resveratrol. Resveratrol increased phosphorylation of TCF4 at serine/threonineresidues through ERK (extracellular signal-regulated kinases) and p38-dependent pathways. The TCF4 knockdown decreased TCF/β-catenin-mediated transcriptional activity and sensitized resveratrol-induced apoptosis. The current study provides a new mechanistic link between resveratrol and TCF4 down-regulation and significant benefits for further preclinical and clinical practice.

【 授权许可】

Unknown